<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39376831</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>A Case of Catheter-Associated Urinary Tract Infection by Pseudomonas mendocina in the Setting of COVID-19.</ArticleTitle><Pagination><StartPage>e68900</StartPage><MedlinePgn>e68900</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e68900</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.68900</ELocationID><Abstract><AbstractText>Pseudomonas mendocina, a Gram-negative, aerobic bacillus, has rarely been implicated in human infections. This report details the first documented case of catheter-associated urinary tract infection (CAUTI) caused by P. mendocina in a COVID-19-positive patient. We present the case of a 70-year-old male with obstructive uropathy who presented with altered mental status eight days after testing positive for COVID-19. Urine cultures identified P. mendocina and Enterococcus faecalis. The antibiotic regimen was adjusted to cefepime and fosfomycin for coverage against P. mendocina and E. faecalis, respectively, resulting in the patient's improvement and discharge with an outpatient course of ciprofloxacin. However, the patient was readmitted 12 days later for recurrent symptoms and traumatic catheter removal, requiring nephrostomy tube placement. Follow-up revealed severe bladder and prostate abnormalities, confirming a complex interplay of factors contributing to his infection. P. mendocina is a rare opportunistic pathogen, often occurring in patients with pre-existing health conditions. This case is significant as the first CAUTI caused by P. mendocina and highlights potential links between COVID-19 and increased susceptibility to bacterial infections. The patient's comorbidities, particularly obstructive uropathy, and prolonged catheter use, were likely major factors in his infection. The role of COVID-19 in facilitating bacterial colonization remains speculative but warrants further investigation. This case report underscores the need for heightened clinical awareness and prompt intervention in patients with similar risk factors. The successful treatment regimen provides a valuable reference for managing such infections. Further research is needed to explore the interplay between viral and bacterial infections, particularly in the context of COVID-19.</AbstractText><CopyrightInformation>Copyright © 2024, Penney et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Penney</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Medicine, California Northstate University, Elk Grove, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Medicine, California Northstate University, Elk Grove, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sands</LastName><ForeName>Nathaniel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>College of Medicine, California Northstate University, Elk Grove, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaikwad</LastName><ForeName>Ritu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>College of Medicine, California Northstate University, Elk Grove, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akhter</LastName><ForeName>Mutaal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Mercy General Hospital, Sacramento, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">catheter-associated uti</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">obstructive uropathy</Keyword><Keyword MajorTopicYN="N">pseudomonas mendocina</Keyword><Keyword MajorTopicYN="N">uti</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39376831</ArticleId><ArticleId IdType="pmc">PMC11458280</ArticleId><ArticleId IdType="doi">10.7759/cureus.68900</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walsh D. Pseudomonas mendocina.  [
Sep;
2024 
]. 2014. https://microbewiki.kenyon.edu/index.php/Pseudomonas_mendocina https://microbewiki.kenyon.edu/index.php/Pseudomonas_mendocina</Citation></Reference><Reference><Citation>Pseudomonas mendocina urinary tract infection: a case report and literature review. Vo T, Maisuradze N, Maglakelidze D, Kalra T, McFarlane IM. Cureus. 2022;14:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9045790</ArticleId><ArticleId IdType="pubmed">35495004</ArticleId></ArticleIdList></Reference><Reference><Citation>Pseudomonas mendocina native valve infective endocarditis: a case report. Rapsinski GJ, Makadia J, Bhanot N, Min Z. J Med Case Rep. 2016;10:275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5048412</ArticleId><ArticleId IdType="pubmed">27716406</ArticleId></ArticleIdList></Reference><Reference><Citation>Pseudomonas mendocina bacteremia: a case study and review of literature. Gani M, Rao S, Miller M, Scoular S. Am J Case Rep. 2019;20:453–458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463785</ArticleId><ArticleId IdType="pubmed">30948701</ArticleId></ArticleIdList></Reference><Reference><Citation>Pseudomonas mendocina bacteremia in a hemodialysis patient with a central venous catheter. Goldberg ME, Blyth M, Swiatlo E. Cureus. 2020;12:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652019</ArticleId><ArticleId IdType="pubmed">33178507</ArticleId></ArticleIdList></Reference><Reference><Citation>A case of pseudomonas mendocina bacteremia in an elderly man with bilateral leg lesions. Ezeokoli EU, Polat MU, Ogundipe O, Szela J. Cureus. 2021;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494157</ArticleId><ArticleId IdType="pubmed">34659988</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus-bacteria interactions: an emerging topic in human infection. Almand EA, Moore MD, Jaykus LA. Viruses. 2017;9:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5371813</ArticleId><ArticleId IdType="pubmed">28335562</ArticleId></ArticleIdList></Reference><Reference><Citation>De novo or increasing lower urinary tract symptoms during COVID-19 infection: long-term results. Köse O, Atik YT, Erdik A, et al. J Mens Health. 2022;18:161.</Citation></Reference><Reference><Citation>The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Li W, Sui J, Huang IC, et al. Virology. 2007;367:367–374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693060</ArticleId><ArticleId IdType="pubmed">17631932</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacterial co-infections with SARS-CoV-2. Mirzaei R, Goodarzi P, Asadi M, et al. IUBMB Life. 2020;72:2097–2111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436231</ArticleId><ArticleId IdType="pubmed">32770825</ArticleId></ArticleIdList></Reference><Reference><Citation>Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? Lai CC, Wang CY, Hsueh PR. J Microbiol Immunol Infect. 2020;53:505–512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245213</ArticleId><ArticleId IdType="pubmed">32482366</ArticleId></ArticleIdList></Reference><Reference><Citation>Co-infection with respiratory pathogens among COVID-2019 cases. Zhu X, Ge Y, Wu T, et al. Virus Res. 2020;285:198005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213959</ArticleId><ArticleId IdType="pubmed">32408156</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglewski BH. Medical Microbiology, 4th Edition. Galveston, TX: University of Texas Medical Branch at Galveston; 1996. Pseudomonas.</Citation><ArticleIdList><ArticleId IdType="pubmed">21413324</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicastri E, Leone S. Guide to Infection Control in the Healthcare Setting. Massachusetts, US: International Society for Infectious Diseases; 2021. Healthcare associated urinary tract infections.</Citation></Reference><Reference><Citation>Role of duration of catheterization and length of hospital stay on the rate of catheter-related hospital-acquired urinary tract infections. Al-Hazmi H. Res Rep Urol. 2015;7:41–47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4378875</ArticleId><ArticleId IdType="pubmed">25848551</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter-associated urinary tract infections: current challenges and future prospects. Werneburg GT. Res Rep Urol. 2022;14:109–133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8992741</ArticleId><ArticleId IdType="pubmed">35402319</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>